Susan Elizabeth Arnold Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Susan Elizabeth Arnold.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Susan Elizabeth Arnold. Susan Elizabeth Arnold is VP, Preclinical and Chem in PhaseBio Pharmaceuticals Inc ($PHAS) and VP, Preclinical and Chem. in PhaseBio Pharmaceuticals Inc ($PHAS).
Latest Insider Trading Transactions of Susan Elizabeth Arnold
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 24 2021 | PHAS | PhaseBio Pharmaceu ... | Arnold Susan Elizabeth | VP, Preclinical and ... | Grant | A | 2.80 | 5,257 | 14,720 | 23,241 | 18 K to 23.2 K (+29.23 %) |
| Feb 09 2021 | PHAS | PhaseBio Pharmaceu ... | Arnold Susan Elizabeth | VP, Preclinical and ... | Option Exercise | A | 4.31 | 36,000 | 155,160 | 36,000 | |
| Feb 09 2021 | PHAS | PhaseBio Pharmaceu ... | Arnold Susan Elizabeth | VP, Preclinical and ... | Option Exercise | A | 4.31 | 36,000 | 155,160 | 36,000 | |
| Nov 23 2020 | PHAS | PhaseBio Pharmaceu ... | Arnold Susan Elizabeth | VP, Preclinical and ... | Grant | A | 3.00 | 4,832 | 14,496 | 17,984 | 13.2 K to 18 K (+36.74 %) |
| Oct 05 2020 | PHAS | PhaseBio Pharmaceu ... | Arnold Susan Elizabeth | VP, Preclinical and ... | Option Exercise | M | 1.15 | 5,423 | 6,236 | 0 | |
| Oct 05 2020 | PHAS | PhaseBio Pharmaceu ... | Arnold Susan Elizabeth | VP, Preclinical and ... | Option Exercise | M | 1.15 | 5,423 | 6,236 | 0 | |
| Oct 05 2020 | PHAS | PhaseBio Pharmaceu ... | Arnold Susan Elizabeth | VP, Preclinical and ... | Buy | M | 1.15 | 5,423 | 6,236 | 13,152 | 7.7 K to 13.2 K (+70.16 %) |
| Oct 05 2020 | PHAS | PhaseBio Pharmaceu ... | Arnold Susan Elizabeth | VP, Preclinical and ... | Buy | M | 1.15 | 5,423 | 6,236 | 7,729 | 2.3 K to 7.7 K (+235.17 %) |
| Feb 14 2020 | PHAS | PhaseBio Pharmaceu ... | Arnold Susan Elizabeth | VP, Preclinical and ... | Option Exercise | A | 5.19 | 55,000 | 285,450 | 55,000 | |
| Mar 01 2019 | PHAS | PhaseBio Pharmaceu ... | Arnold Susan Elizabeth | VP, Preclinical and ... | Option Exercise | A | 3.15 | 45,000 | 141,750 | 45,000 | |
| Mar 01 2019 | PHAS | PhaseBio Pharmaceu ... | Arnold Susan Elizabeth | VP, Preclinical and ... | Option Exercise | A | 3.15 | 45,000 | 141,750 | 45,000 | |
| Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Arnold Susan Elizabeth | VP, Preclinical and ... | Option Exercise | C | 0.00 | 2,306 | 0 | 0 | |
| Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Arnold Susan Elizabeth | VP, Preclinical and ... | Option Exercise | M | 0.00 | 103 | 0 | 2,306 | |
| Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Arnold Susan Elizabeth | VP, Preclinical and ... | Option Exercise | M | 0.12 | 103 | 12 | 0 | |
| Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | Arnold Susan Elizabeth | VP, Preclinical and ... | Buy | C | 0.00 | 2,306 | 0 | 2,306 | 0 to 2.3 K |
Page: 1